vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and CASELLA WASTE SYSTEMS INC (CWST). Click either name above to swap in a different company.

CASELLA WASTE SYSTEMS INC is the larger business by last-quarter revenue ($557.2M vs $487.7M, roughly 1.1× CLOVER HEALTH INVESTMENTS, CORP.). CASELLA WASTE SYSTEMS INC runs the higher net margin — -1.0% vs -10.1%, a 9.1% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 9.6%). CASELLA WASTE SYSTEMS INC produced more free cash flow last quarter ($30.7M vs $-69.0M). Over the past eight quarters, CASELLA WASTE SYSTEMS INC's revenue compounded faster (21.5% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Casella Waste Systems, Inc. is a waste management company based in Rutland, Vermont, United States. Founded in 1975 with a single truck, Casella is a regional, vertically integrated solid waste services company. Casella provides resource management expertise and services to residential, commercial, municipal and industrial customers, primarily in the areas of solid waste collection and disposal, transfer, recycling and organics services. The company provides integrated solid waste services in...

CLOV vs CWST — Head-to-Head

Bigger by revenue
CWST
CWST
1.1× larger
CWST
$557.2M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+35.1% gap
CLOV
44.7%
9.6%
CWST
Higher net margin
CWST
CWST
9.1% more per $
CWST
-1.0%
-10.1%
CLOV
More free cash flow
CWST
CWST
$99.6M more FCF
CWST
$30.7M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CWST
CWST
Annualised
CWST
21.5%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
CWST
CWST
Revenue
$487.7M
$557.2M
Net Profit
$-49.3M
$-5.5M
Gross Margin
Operating Margin
-10.1%
0.9%
Net Margin
-10.1%
-1.0%
Revenue YoY
44.7%
9.6%
Net Profit YoY
-123.2%
-15.2%
EPS (diluted)
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
CWST
CWST
Q1 26
$557.2M
Q4 25
$487.7M
$469.1M
Q3 25
$496.6M
$485.4M
Q2 25
$477.6M
$465.3M
Q1 25
$462.3M
$417.1M
Q4 24
$337.0M
$427.5M
Q3 24
$331.0M
$411.6M
Q2 24
$356.3M
$377.2M
Net Profit
CLOV
CLOV
CWST
CWST
Q1 26
$-5.5M
Q4 25
$-49.3M
$-2.5M
Q3 25
$-24.4M
$10.0M
Q2 25
$-10.6M
$5.2M
Q1 25
$-1.3M
$-4.8M
Q4 24
$-22.1M
$4.9M
Q3 24
$-9.2M
$5.8M
Q2 24
$7.4M
$7.0M
Gross Margin
CLOV
CLOV
CWST
CWST
Q1 26
Q4 25
33.3%
Q3 25
35.0%
Q2 25
33.8%
Q1 25
32.8%
Q4 24
33.2%
Q3 24
24.5%
35.1%
Q2 24
30.3%
35.4%
Operating Margin
CLOV
CLOV
CWST
CWST
Q1 26
0.9%
Q4 25
-10.1%
2.5%
Q3 25
-4.9%
6.1%
Q2 25
-2.2%
4.1%
Q1 25
-0.3%
0.8%
Q4 24
-6.4%
4.3%
Q3 24
-2.7%
5.9%
Q2 24
2.0%
6.1%
Net Margin
CLOV
CLOV
CWST
CWST
Q1 26
-1.0%
Q4 25
-10.1%
-0.5%
Q3 25
-4.9%
2.1%
Q2 25
-2.2%
1.1%
Q1 25
-0.3%
-1.2%
Q4 24
-6.6%
1.1%
Q3 24
-2.8%
1.4%
Q2 24
2.1%
1.9%
EPS (diluted)
CLOV
CLOV
CWST
CWST
Q1 26
$-0.09
Q4 25
$-0.04
Q3 25
$0.16
Q2 25
$0.08
Q1 25
$-0.08
Q4 24
$0.08
Q3 24
$0.10
Q2 24
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
CWST
CWST
Cash + ST InvestmentsLiquidity on hand
$78.3M
$126.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$1.6B
Total Assets
$541.0M
$3.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
CWST
CWST
Q1 26
$126.9M
Q4 25
$78.3M
$123.8M
Q3 25
$192.7M
Q2 25
$217.8M
Q1 25
$267.7M
Q4 24
$194.5M
$358.3M
Q3 24
$288.0M
$519.0M
Q2 24
$254.8M
$208.5M
Total Debt
CLOV
CLOV
CWST
CWST
Q1 26
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.0B
Q2 24
$976.6M
Stockholders' Equity
CLOV
CLOV
CWST
CWST
Q1 26
$1.6B
Q4 25
$308.7M
$1.6B
Q3 25
$340.9M
$1.6B
Q2 25
$344.2M
$1.6B
Q1 25
$336.1M
$1.5B
Q4 24
$341.1M
$1.6B
Q3 24
$342.2M
$1.5B
Q2 24
$324.9M
$1.0B
Total Assets
CLOV
CLOV
CWST
CWST
Q1 26
$3.3B
Q4 25
$541.0M
$3.3B
Q3 25
$559.7M
$3.3B
Q2 25
$575.0M
$3.3B
Q1 25
$583.7M
$3.2B
Q4 24
$580.7M
$3.2B
Q3 24
$653.0M
$3.1B
Q2 24
$674.2M
$2.5B
Debt / Equity
CLOV
CLOV
CWST
CWST
Q1 26
Q4 25
0.72×
Q3 25
0.72×
Q2 25
0.72×
Q1 25
0.72×
Q4 24
0.70×
Q3 24
0.68×
Q2 24
0.94×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
CWST
CWST
Operating Cash FlowLast quarter
$-66.9M
$62.3M
Free Cash FlowOCF − Capex
$-69.0M
$30.7M
FCF MarginFCF / Revenue
-14.1%
5.5%
Capex IntensityCapex / Revenue
0.4%
9.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$120.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
CWST
CWST
Q1 26
$62.3M
Q4 25
$-66.9M
$96.6M
Q3 25
$12.1M
$93.6M
Q2 25
$5.4M
$89.5M
Q1 25
$-16.3M
$50.1M
Q4 24
$34.8M
$109.8M
Q3 24
$50.0M
$91.8M
Q2 24
$44.8M
$72.1M
Free Cash Flow
CLOV
CLOV
CWST
CWST
Q1 26
$30.7M
Q4 25
$-69.0M
$39.3M
Q3 25
$11.4M
$27.6M
Q2 25
$4.8M
$23.1M
Q1 25
$-16.5M
$-5.4M
Q4 24
$33.3M
$32.9M
Q3 24
$49.6M
$40.4M
Q2 24
$44.4M
$27.5M
FCF Margin
CLOV
CLOV
CWST
CWST
Q1 26
5.5%
Q4 25
-14.1%
8.4%
Q3 25
2.3%
5.7%
Q2 25
1.0%
5.0%
Q1 25
-3.6%
-1.3%
Q4 24
9.9%
7.7%
Q3 24
15.0%
9.8%
Q2 24
12.5%
7.3%
Capex Intensity
CLOV
CLOV
CWST
CWST
Q1 26
9.0%
Q4 25
0.4%
12.2%
Q3 25
0.1%
13.6%
Q2 25
0.1%
14.3%
Q1 25
0.0%
13.3%
Q4 24
0.5%
18.0%
Q3 24
0.1%
12.5%
Q2 24
0.1%
11.8%
Cash Conversion
CLOV
CLOV
CWST
CWST
Q1 26
Q4 25
Q3 25
9.37×
Q2 25
17.19×
Q1 25
Q4 24
22.51×
Q3 24
15.91×
Q2 24
6.04×
10.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

CWST
CWST

Collection$334.8M60%
Transfer station$65.9M12%
Processing (ii)$49.0M9%
Landfill$48.0M9%
National Accounts (ii)$45.6M8%
Transportation$8.2M1%
Landfill gas-to-energy$2.9M1%

Related Comparisons